AU7079098A - Pharmaceutical composition for supressing type 2 helper t cell immune respons - Google Patents

Pharmaceutical composition for supressing type 2 helper t cell immune respons

Info

Publication number: AU7079098A
Authority: AU; Australia
Prior art keywords: supressing; helper; type; pharmaceutical composition; cell immune
Prior art date: 1997-04-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU70790/98A

Inventor

Yuso Goto

Hiroshi Ochi

Hideyuki Tomizawa

Takamasa Watanabe

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eneos Corp

Sumitomo Pharma Co Ltd

Original Assignee

Sumitomo Pharmaceuticals Co Ltd

Japan Energy Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-25

Filing date

1998-04-22

Publication date

1998-11-24

1998-04-22 Application filed by Sumitomo Pharmaceuticals Co Ltd, Japan Energy Corp filed Critical Sumitomo Pharmaceuticals Co Ltd

1998-11-24 Publication of AU7079098A publication Critical patent/AU7079098A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AU70790/98A 1997-04-25 1998-04-22 Pharmaceutical composition for supressing type 2 helper t cell immune respons Abandoned AU7079098A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP9-123146		1997-04-25
JP9123146A JPH10298181A (en)	1997-04-25	1997-04-25	Type 2 helper T cell selective immune response inhibitor
PCT/JP1998/001841 WO1998048805A1 (en)	1997-04-25	1998-04-22	Pharmaceutical composition for supressing type 2 helper t cell immune response

Publications (1)

Publication Number	Publication Date
AU7079098A true AU7079098A (en)	1998-11-24

Family

ID=14853339

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU70790/98A Abandoned AU7079098A (en)	1997-04-25	1998-04-22	Pharmaceutical composition for supressing type 2 helper t cell immune respons

Country Status (4)

Country	Link
EP (1)	EP0977569A1 (en)
JP (1)	JPH10298181A (en)
AU (1)	AU7079098A (en)
WO (1)	WO1998048805A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6541485B1 (en) *	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6451810B1 (en) *	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6331539B1 (en)	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6756382B2 (en)	1999-06-10	2004-06-29	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6573273B1 (en)	1999-06-10	2003-06-03	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6869956B2 (en) *	2000-10-03	2005-03-22	Bristol-Myers Squibb Company	Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
MXPA04008023A (en) *	2002-02-22	2004-11-26	3M Innovative Properties Co	Method of reducing and treating uvb-induced immunosuppression.
KR101494056B1 (en) *	2003-10-03	2015-02-16	쓰리엠 이노베이티브 프로퍼티즈 컴파니	Pyrazolopyridines and analogs thereof
BRPI0414856A (en)	2003-10-03	2006-11-21	3M Innovative Properties Co	alkoxy-substituted imidazoquinolines
EP1687307B1 (en)	2003-11-25	2016-01-06	3M Innovative Properties Company	Substituted imidazo ring systems and methods
US9248127B2 (en)	2005-02-04	2016-02-02	3M Innovative Properties Company	Aqueous gel formulations containing immune response modifiers
CN101304748A (en)	2005-08-22	2008-11-12	加利福尼亚大学董事会	TLR agonist
WO2007142755A2 (en)	2006-05-31	2007-12-13	The Regents Of The University Of California	Purine analogs
SI2510946T1 (en)	2007-02-07	2015-12-31	The Regents Of The University Of California	Conjugates of synthetic tlr agonists and uses therefor
CA2708203A1 (en) *	2008-01-15	2009-07-23	Dow Pharmaceutical Sciences, Inc.	Imiquimod formulation
WO2010050584A1 (en) *	2008-10-31	2010-05-06	独立行政法人科学技術振興機構	Method for selectively controlling function of helper t cell
WO2010088924A1 (en)	2009-02-06	2010-08-12	Telormedix Sa	Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
US11697851B2 (en)	2016-05-24	2023-07-11	The Regents Of The University Of California	Early ovarian cancer detection diagnostic test based on mRNA isoforms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1271477A (en) *	1983-11-18	1990-07-10	John F. Gerster	1h-imidazo[4,5-c]quinolin-4-amines
CA2289219C (en) *	1991-03-01	2003-05-20	Minnesota Mining And Manufacturing Company	1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines
US5268376A (en) *	1991-09-04	1993-12-07	Minnesota Mining And Manufacturing Company	1-substituted 1H-imidazo[4,5-c]quinolin-4-amines

1997
- 1997-04-25 JP JP9123146A patent/JPH10298181A/en active Pending
1998
- 1998-04-22 AU AU70790/98A patent/AU7079098A/en not_active Abandoned
- 1998-04-22 EP EP98917620A patent/EP0977569A1/en not_active Withdrawn
- 1998-04-22 WO PCT/JP1998/001841 patent/WO1998048805A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
JPH10298181A (en)	1998-11-10
WO1998048805A1 (en)	1998-11-05
EP0977569A1 (en)	2000-02-09

Publication	Publication Date	Title
AU7572196A (en)	1997-06-11	Pharmaceutical formulations
EG23826A (en)	2007-09-25	Pharmaceutical formulations
AU6216296A (en)	1997-03-06	Pharmaceutical compositions
AU3049397A (en)	1997-10-22	Cyclosporin-containing pharmaceutical composition
EP1001813B8 (en)	2014-02-12	Pharmaceutical formulations containing voriconazole
AU7079098A (en)	1998-11-24	Pharmaceutical composition for supressing type 2 helper t cell immune respons
AU6011496A (en)	1997-01-09	Improved pharmaceutical compositions for gene therapy
AU4762797A (en)	1998-06-18	Pharmaceutical compositions
AU2967597A (en)	1998-01-05	Pharmaceutical compositions
AU8107998A (en)	1998-12-11	Pharmaceutical compositions
AU3777897A (en)	1998-03-06	Pharmaceutical compositions
AU5317598A (en)	1998-05-29	Novel pharmaceutical compositions
AU4326197A (en)	1998-02-02	Pharmaceutical compositions
AU5155096A (en)	1996-10-30	Pharmaceutical composition
EG24294A (en)	2009-01-08	Pharmaceutical compositions
AU7904998A (en)	1999-02-08	Pharmaceutical composition containing peptichemio
AU5274096A (en)	1996-10-16	Pharmaceutical compositions
ZA96525B (en)	1996-08-06	Novel pharmaceutical compositions
AU9343098A (en)	1999-03-08	Pharmaceutical composition
ZA96526B (en)	1996-08-06	Novel pharmaceutical formulation
AU1509799A (en)	1999-06-28	Pharmaceutical composition containing cyclosporin
AU2087897A (en)	1997-10-01	Pharmaceutical compositions
AU4457597A (en)	1998-03-26	Pharmaceutical compositions
AU1427895A (en)	1995-08-01	Pharmaceutical compositions
AU1544195A (en)	1995-08-01	Pharmaceutical compositions

Legal Events

Date	Code	Title	Description
2000-01-13	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase